Simplex Trading, LLC Pharma Cyte Biotech, Inc. Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$2.09 - $2.89 $98,125 - $135,685	-46,950 Reduced 99.58%	199 $0
Q2 2023 Aug 04, 2023	SELL	$2.74 - $3.18 $235,779 - $273,642	-86,051 Reduced 64.6%	47,149 $134,000
Q1 2023 Apr 27, 2023	BUY	$2.83 - $3.03 $196,945 - $210,863	69,592 Added 109.41%	133,200 $387,000
Q4 2022 Feb 02, 2023	SELL	$2.72 - $3.07 $4,928 - $5,562	-1,812 Reduced 2.77%	63,608 $186,000
Q3 2022 Nov 04, 2022	BUY	$2.24 - $2.85 $23,504 - $29,905	10,493 Added 19.1%	65,420 $157,000

Q2 2022 Aug 03, 2022	BUY	$1.99 - $2.33 $109,304 - $127,979	54,927 New	54,927 $123,000

1.07M

5.4K

400

Ticker PMCB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,750,100
Market Cap $41.5M
Description
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.